[RPRX] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[RPRX] Royalty Pharma plc
Announcement Date
08-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -68.32%
YoY- -66.89%
Quarter Report
RPRX's Result
RPRX's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 537,267 567,978 596,000 536,313 538,202 683,971 565,748 -3.38%
PBT 194,377 -4,273 718,000 122,077 351,336 509,089 -610,030 -
Tax 92,373 -9,051 223,000 49,963 123,711 168,334 139 7545.51%
NP 102,004 4,778 494,340 72,114 227,625 340,755 -610,169 -
Tax Rate -47.52% - -31.06% -40.93% -35.21% -33.07% - -
Total Cost 435,263 563,200 101,660 464,199 310,577 343,216 1,175,917 -48.47%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin 18.99 0.84 82.94 13.45 42.29 49.82 -107.85 -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS 0.23 0.01 1.11 0.16 0.51 0.76 -1.38 -
EPS Diluted 0.23 0.01 1.11 0.16 0.50 0.76 -1.38 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.